BR112022025128A2 - Composições e métodos para tratar doenças e distúrbios usando vesículas extracelulares microbianas de oscillospiraceae - Google Patents

Composições e métodos para tratar doenças e distúrbios usando vesículas extracelulares microbianas de oscillospiraceae

Info

Publication number
BR112022025128A2
BR112022025128A2 BR112022025128A BR112022025128A BR112022025128A2 BR 112022025128 A2 BR112022025128 A2 BR 112022025128A2 BR 112022025128 A BR112022025128 A BR 112022025128A BR 112022025128 A BR112022025128 A BR 112022025128A BR 112022025128 A2 BR112022025128 A2 BR 112022025128A2
Authority
BR
Brazil
Prior art keywords
oscillospiraceae
methods
extracellular vesicles
disorders
compositions
Prior art date
Application number
BR112022025128A
Other languages
English (en)
Inventor
Ballok Alicia
Francisco-Anderson Loise
Sizova Maria
Original Assignee
Evelo Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evelo Biosciences Inc filed Critical Evelo Biosciences Inc
Publication of BR112022025128A2 publication Critical patent/BR112022025128A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5063—Compounds of unknown constitution, e.g. material from plants or animals
    • A61K9/5068—Cell membranes or bacterial membranes enclosing drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Rheumatology (AREA)
  • Botany (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Physiology (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

COMPOSIÇÕES E MÉTODOS PARA TRATAR DOENÇAS E DISTÚRBIOS USANDO VESÍCULAS EXTRACELULARES MICROBIANAS DE OSCILLOSPIRACEAE. A presente invenção refere-se a métodos e composições farmacêuticas relacionadas a vesículas extracelulares microbianas (mEVs) obtidas a partir de bactérias Oscillospiraceae que podem ser úteis como agentes terapêuticos.
BR112022025128A 2020-06-11 2021-06-11 Composições e métodos para tratar doenças e distúrbios usando vesículas extracelulares microbianas de oscillospiraceae BR112022025128A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063037771P 2020-06-11 2020-06-11
PCT/US2021/036978 WO2021252877A1 (en) 2020-06-11 2021-06-11 Compositions and methods for treating diseases and disorders using oscillospiraceae microbial extracellular vesicles

Publications (1)

Publication Number Publication Date
BR112022025128A2 true BR112022025128A2 (pt) 2023-01-17

Family

ID=76999938

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022025128A BR112022025128A2 (pt) 2020-06-11 2021-06-11 Composições e métodos para tratar doenças e distúrbios usando vesículas extracelulares microbianas de oscillospiraceae

Country Status (13)

Country Link
US (1) US20230263838A1 (pt)
EP (1) EP4164664A1 (pt)
JP (1) JP2023530413A (pt)
KR (1) KR20230038476A (pt)
CN (1) CN115942944A (pt)
AR (1) AR122610A1 (pt)
AU (1) AU2021287978A1 (pt)
BR (1) BR112022025128A2 (pt)
CA (1) CA3180044A1 (pt)
CO (1) CO2023000114A2 (pt)
MX (1) MX2022015630A (pt)
TW (1) TW202214274A (pt)
WO (1) WO2021252877A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022140396A1 (en) * 2020-12-22 2022-06-30 Evelo Biosciences, Inc. Compositions comprising animal hemoglobin
WO2023158204A1 (en) * 2022-02-15 2023-08-24 Enterobiome Inc. Pharmaceutical composition for preventing or treating cancer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101833502B1 (ko) * 2016-12-16 2018-03-05 주식회사 엠디헬스케어 세균 메타게놈 분석을 통한 위암 진단방법
KR101833503B1 (ko) * 2016-12-26 2018-03-05 주식회사 엠디헬스케어 만성폐쇄성폐질환자에서 세균 메타게놈 분석을 통한 폐암 진단방법
MX2020002659A (es) * 2017-09-08 2020-09-09 Evelo Biosciences Inc Vesiculas extracelulares bacterianas.
CN111601610A (zh) * 2017-11-14 2020-08-28 伊夫罗生物科学公司 使用布劳特氏菌属菌株治疗疾病的组合物和方法
CN111712260A (zh) * 2018-01-31 2020-09-25 伊夫罗生物科学公司 使用毛螺菌科细菌治疗免疫病症的组合物和方法
TW202140051A (zh) * 2020-01-17 2021-11-01 美商艾弗洛生物科技股份有限公司 具有改善的崩散譜之固體劑型

Also Published As

Publication number Publication date
EP4164664A1 (en) 2023-04-19
CA3180044A1 (en) 2021-12-16
AU2021287978A1 (en) 2023-02-02
WO2021252877A1 (en) 2021-12-16
CO2023000114A2 (es) 2023-01-16
KR20230038476A (ko) 2023-03-20
JP2023530413A (ja) 2023-07-18
CN115942944A (zh) 2023-04-07
TW202214274A (zh) 2022-04-16
US20230263838A1 (en) 2023-08-24
MX2022015630A (es) 2023-01-11
AR122610A1 (es) 2022-09-21

Similar Documents

Publication Publication Date Title
MX2022001607A (es) Composiciones y metodos para tratar la psoriasis y la dermatitis atopica usando prevotella histicola.
BR112021024830A2 (pt) Vesículas extracelulares microbianas processadas
MX2022001770A (es) Vesícula extracelular unida a moléculas y usos de esta.
CO2023000114A2 (es) Composiciones y métodos para el tratamiento de enfermedades y trastornos usando vesículas extracelulares microbianas de oscillospiraceae
BR112017007975A2 (pt) composições e métodos para o tratamento de disfunção das glândulas meibomianas
MX2016014634A (es) Compuestos para el tratamiento de enfermedades y trastornos oftalmicos.
PH12020551425A1 (en) Rimegepant for cgrp related disorders
BR112015005117A2 (pt) métodos de tratamento da doença de alzheimer e suas composições farmacêuticas
EA201071243A1 (ru) Комбинированные композиции для лечения болезни альцгеймера и родственных заболеваний зонизамидом и акампросатом
BR112014014783A2 (pt) moléculas de inibidor de jnk para tratamento de várias doenças
EP3818991A3 (en) Compositions and methods for treating diseases
CL2020001495A1 (es) Composiciones y método para el tratamiento de enfermedades metabólicas
ECSP22086300A (es) Composiciones que comprenden nanopartículas, método de elaboración y usos de las mismas
EA202190308A1 (ru) Применение пролекарств рилузола для лечения болезни альцгеймера
CO2023001509A2 (es) Cepa c de prevotella histicola como terapia oral para enfermedades inflamatorias
BR112015019802A2 (pt) formulações farmacêuticas de nitrito e usos das mesmas
MX2022014925A (es) Moduladores de il-17a.
MX2022014924A (es) Moduladores de il-17a.
CO2021000229A2 (es) Compuestos de pirazol e imidazol para la inhibición de il-17 y rorgamma
MX2021003006A (es) Bacterioterapia contra proprionibacterium acnes para el tratamiento de acne.
MX2021007330A (es) Composiciones y métodos terapéuticos para tratar cáncer usando ácido 6, 8-bis-benciltio-octanoico y un inhibidor de autofagia.
UA112418C2 (uk) Терапевтичний болезаспокійливий засіб
WO2021252860A3 (en) Compositions and methods for treating diseases and disorders using harryflintia acetispora
BR112014011336A2 (pt) composições farmacêuticas que compreendem 7-(1h-imidazol-4-ilmetil)-5,6,7,8-tetra-hidro-quinolina para tratamento de doenças e condições de pele
EP2566856A4 (en) COMPOUNDS AND METHODS FOR TREATING CEREBRAL DISORDERS